Steven C. Gilman
Senior Vice President, Cubist Pharmaceuticals.
Companies
- Akebia Therapeutics, Inc.Board member Dec 13, 2018 to now1
- SCYNEXIS INCBoard member Feb 27, 2015 to now2
- VericelBoard member Jan 7, 2015 to Oct 18, 20243
- CONTRAFECT CorpBoard member May 20, 2015 to May 18, 20224
- CONTRAFECT CorpChief executive officer Mar 23, 2016 to Feb 7, 20195
- Cubist PharmaceuticalsSenior Vice President Feb 14, 2008 to Jan 21, 20156
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Vericel VCEL11,000 shares7$443.7K at $40.34Oct 16, 2024
- SCYNEXIS INC SCYX70,000 shares8$260.4K at $3.72Jun 26, 2025
- Akebia Therapeutics, Inc. AKBA152,830 shares9$107.9K at $0.71Jun 10, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 26, 2025Granted 23,000 shares of SCYNEXIS INC8
- Jun 10, 2025Granted 35,700 shares of Akebia Therapeutics, Inc.9
- Oct 16, 2024Sold 5,833 shares at $41.36 of Vericel7
- Oct 16, 2024Exercised options 5,833 shares at $13.05 of Vericel7
- Oct 2, 2024Sold 5,833 shares at $40.35 of Vericel10
- Oct 2, 2024Exercised options 5,833 shares at $13.05 of Vericel10
- Sep 18, 2024Sold 5,834 shares at $45.54 of Vericel11
- Sep 18, 2024Exercised options 5,834 shares at $13.05 of Vericel11
- Sep 4, 2024Sold 5,000 shares at $48.58 of Vericel12
- Sep 4, 2024Exercised options 5,000 shares at $3.74 of Vericel12
- Jun 20, 2024Granted 23,000 shares of SCYNEXIS INC13
- Jun 6, 2024Granted 30,000 shares of Akebia Therapeutics, Inc.14
- May 1, 2024Exercised options 3,200 shares of Vericel15
- Jun 15, 2023Granted 10,000 shares of SCYNEXIS INC16
- Jun 6, 2023Granted 30,000 shares of Akebia Therapeutics, Inc.17
- Apr 27, 2023Exercised options 2,600 shares of Vericel18
- Jun 17, 2022Granted 10,000 shares of SCYNEXIS INC19
- Jun 8, 2022Granted 13,700 shares of Akebia Therapeutics, Inc.20
- Jun 3, 2022Sold 4,567 shares at $0.36 of Akebia Therapeutics, Inc.21
- Apr 29, 2022Sold 900 shares at $30.94 of Vericel22
- Apr 27, 2022Exercised options 2,600 shares of Vericel23
- Nov 29, 2021Sold 5,000 shares at $39.17 of Vericel24
- Nov 29, 2021Exercised options 5,000 shares at $3.74 of Vericel24
- Oct 27, 2021Sold 5,000 shares at $50.57 of Vericel25
- Oct 27, 2021Exercised options 5,000 shares at $3.74 of Vericel25
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARSCYNEXIS INC, Board member
- 3SEC EDGARVericel, Board member
- 4SEC EDGARCONTRAFECT Corp, Board member
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Oct 4, 2024
- 11SEC EDGARForm 4 filed Sep 20, 2024
- 12SEC EDGARForm 4 filed Sep 5, 2024
- 13SEC EDGARForm 4 filed Jun 21, 2024
- 14SEC EDGARForm 4 filed Jun 10, 2024
- 15SEC EDGARForm 4 filed May 3, 2024
- 16SEC EDGARForm 4 filed Jun 23, 2023
- 17SEC EDGARForm 4 filed Jun 8, 2023
- 18SEC EDGARForm 4 filed Apr 28, 2023
- 19SEC EDGARForm 4 filed Jun 22, 2022
- 20SEC EDGARForm 4 filed Jun 9, 2022
- 21SEC EDGARForm 4 filed Jun 7, 2022
- 22SEC EDGARForm 4 filed May 2, 2022
- 23SEC EDGARForm 4 filed Apr 29, 2022
- 24SEC EDGARForm 4 filed Dec 1, 2021
- 25SEC EDGARForm 4 filed Oct 28, 2021